Professor Anthony Chan, MD, FRCP (Lond, Edin, Glas), graduated from the School of Medicine in University College London and received post-graduate training in Medical Oncology at the Royal Marsden Hospital, UK. He is Pro-Vice-Chancellor of The Chinese University of Hong Kong (CUHK), Li Shu Fan Medical Foundation Professor of Clinical Oncology, Director of the Sir YK Pao Centre for Cancer, Hong Kong Cancer Institute, Chief Director of Phase 1 Clinical Trial Centre, Associate Director of State Key Laboratory of Translational Oncology and Master of Wu Yee Sun College. Professor Chan conducted pivotal studies setting new treatment standards in multimodality approaches in nasopharynx cancer, developed the clinical applications of the biomarker EBV DNA and pioneered immunotherapeutic and targeted therapeutics in this disease. He has published extensively in international journals, and also delivered hundreds of international lectures. He has published reviews in Lancet and Nature Review Clinical Oncology as well as European Society for Medical Oncology (ESMO) treatment guidelines for Nasopharyngeal Cancer. He has served on the Editorial Board of Journal of Clinical Oncology and has been Associate Editor of Annals of Oncology since 2014.

Research Interests

Clinical and translational research in Nasopharyngeal Carcinoma (NPC)